It will be of interest to determine whether, in addition to a physiological role in the erythroid stress response, IL-17A contributes to myeloproliferative neoplasms such as polycythemia vera, where it might synergize with the constitutively active JAK2V617F in erythrocyte over-production. This evidence concerns the gene IL17A and myeloproliferative neoplasm.